top of page
Blog
Stay informed about key processes for Medical Devices and the latest FDA updates tailored for manufacturers.
Recent posts
Navigating the FDA 2026 Human Factors Guidance: The Risk-Based Approach
On May 29, 2026, the FDA issued its final guidance on the Content of Human Factors Information in Medical Device Marketing Submissions. This risk-based framework introduces three HF Submission Categories based on critical tasks and device changes. It helps manufacturers streamline CDRH submissions, clarifying when a simple summary suffices versus when comprehensive validation testing is mandatory, improving FDA review efficiency
SANRUBIO, LLC
Jun 93 min read
The QMSR Era: FDA’s Final Move to ISO 13485 Harmonization - Quality Management System and the FDA
As of February 2, 2026, the FDA has officially replaced the old Quality System Regulation (21 CFR 820) with the new Quality Management System Regulation (QMSR). This historic alignment with ISO 13485:2016 streamlines global compliance for medical device manufacturers. This article explores the core changes, the additional FDA-specific requirements, and how this "single audit" reality reduces costs and accelerates market access for international firms.
SANRUBIO, LLC
Mar 202 min read
Search
Key differences between the 510(k) and De Novo submission for FDA Medical Device Authorization
Discover the key differences between FDA’s 510(k) and De Novo pathways for medical device authorization. Learn when to choose each option, their requirements, timelines, and ideal use cases. From substantial equivalence in 510(k) to creating new classifications in De Novo, this guide provides essential insights for manufacturers. Ensure regulatory success with expert strategies and tailored support for your device’s U.S. market entry.
SANRUBIO, LLC
Jun 17, 20253 min read
bottom of page